aztreonam has been researched along with arginine in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (9.09) | 18.7374 |
1990's | 4 (36.36) | 18.2507 |
2000's | 2 (18.18) | 29.6817 |
2010's | 4 (36.36) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Fabre, H; Ibork, H; Lerner, DA | 1 |
Argyle, C; McCracken, G; Mize, C; Uauy, R | 1 |
Morelli, B | 1 |
Billot-Klein, D; Collatz, E; Gutmann, L; Tran Van Nhieu, G; Williamson, R | 1 |
Lazar, M; Loewenstein, A; Perlman, I; Zemel, E | 1 |
Alves Filho, JC; Cunha, FQ; D'Avila, LC; da Cunha, AA; de Oliveira, JR; Dias, FS; Leite, CE; Lunardelli, A; Machado, DP; Nunes, FB; Poli de Figueiredo, CE; Poloni, JA; Ruschel, RE; Saciura, VC; Simões Pires, MG | 1 |
Bonnet, R; Caniça, M; Ferreira, E; Manageiro, V; Mendonça, N; Robin, F; Salgado, MJ | 1 |
1 review(s) available for aztreonam and arginine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for aztreonam and arginine
Article | Year |
---|---|
Metabolic tolerance to arginine: implications for the safe use of arginine salt-aztreonam combination in the neonatal period.
Topics: Ammonia; Ampicillin; Analysis of Variance; Arginine; Aztreonam; Bilirubin; Blood Glucose; Cohort Studies; Drug Evaluation; Drug Therapy, Combination; Gentamicins; Humans; Infant, Low Birth Weight; Infant, Newborn; Sepsis; Time Factors | 1991 |
9 other study(ies) available for aztreonam and arginine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Photodegradation kinetics under UV light of aztreonam solutions.
Topics: Arginine; Aztreonam; Chromatography, High Pressure Liquid; Chromatography, Liquid; Photochemistry; Solutions; Ultraviolet Rays | 1992 |
Simultaneous derivative spectrophotometric determination of aztreonam and L-arginine in injections.
Topics: Arginine; Aztreonam; Chemical Phenomena; Chemistry; Drug Combinations; Indicators and Reagents; Spectrophotometry, Ultraviolet | 1990 |
Substitution of serine for arginine in position 162 of TEM-type beta-lactamases extends the substrate profile of mutant enzymes, TEM-7 and TEM-101, to ceftazidime and aztreonam.
Topics: Amino Acid Sequence; Arginine; Aztreonam; beta-Lactamases; Ceftazidime; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Microbial; Escherichia coli; Genes, Bacterial; Isoelectric Focusing; Mutation; R Factors; Restriction Mapping; Serine; Substrate Specificity | 1989 |
Drug-induced retinal toxicity in albino rabbits: the effects of imipenem and aztreonam.
Topics: Animals; Arginine; Aztreonam; Electroretinography; Evoked Potentials, Visual; Imipenem; Injections; Rabbits; Retina; Vitreous Body | 1993 |
Effects of beta-lactam antibiotics and L-arginine in the treatment of experimental sepsis in rats.
Topics: Animals; Arginine; Ascitic Fluid; Aztreonam; beta-Lactams; Ceftriaxone; Drug Therapy, Combination; Interleukin-10; Interleukin-1beta; Male; Nitrates; Nitrites; Rats; Rats, Wistar; Sepsis; Survival Analysis; Treatment Outcome; Tumor Necrosis Factor-alpha | 2006 |
The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.
Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Arginine; Aztreonam; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Computer Simulation; Imipenem; Isoelectric Focusing; Kinetics; Klebsiella pneumoniae; Lysine; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Penicillins; Protein Conformation; Protein Structure, Tertiary | 2008 |